Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

290.52 +11.31 (+4.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,502,918
Open 280.01
Bid (Size) 290.55 (1)
Ask (Size) 291.99 (1)
Prev. Close 279.21
Today's Range 278.98 - 293.98
52wk Range 253.30 - 346.85
Shares Outstanding 537,700,000
Dividend Yield 3.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%
The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields. 
Via Benzinga
Topics Stocks
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide. 
Via Investor's Business Daily

Performance

YTD
+12.0%
+12.0%
1 Month
+0.7%
+0.7%
3 Month
-6.8%
-6.8%
6 Month
+12.0%
+12.0%
1 Year
-6.6%
-6.6%

More News

Read More
Amgen's Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects
Via Benzinga
Amgen’s Cancer Drug Improves Survival In Late-stage Trial
Via Stocktwits
Topics Death
Is Amgen Stock a Buy?
Via The Motley Fool
2 Dividend Stocks to Buy on the Dip and Hold Forever
Via The Motley Fool
Topics Government Stocks World Trade
Where Amgen Stands With Analysts
Via Benzinga
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues
Via Benzinga
Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Amgen Expands Development Plans For Highly Anticipated Obesity Drug
Via Investor's Business Daily
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Via Benzinga
2 Large-Cap Stocks to Consider Right Now and 1 to Steer Clear Of
Via StockStory
Topics Economy
Amgen Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Elizabeth Warren, Jan Schakowsky Reportedly Seek Answers From Pfizer, Amgen, And Others On Low Federal Tax Bills
Via Stocktwits
Topics Government
Members of Congress Are Pouring Millions Into These 7 Surprising Stocks
Via The Motley Fool
Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency
Via Stocktwits
Unpacking the Latest Options Trading Trends in Amgen
Via Benzinga
The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.
Via Investor's Business Daily
2 Dividend Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Topics Intellectual Property
1 S&P 500 Stock to Consider Right Now and 2 to Steer Clear Of
Via StockStory
Topics Stocks
Amgen Says Its Drug Reduces Risk Of Death By 40% In Small Cell Lung Cancer: Retail’s Yet To Be Convinced
Via Stocktwits
3 No-Brainer Healthcare Stocks to Buy in June
Via The Motley Fool
2 Dow Jones Stocks with Promising Prospects and 1 to Avoid
Via StockStory
Topics Stocks
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 290.52
When was Amgen last traded?
The last trade of Amgen was at 07/01/25 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 156.21B
How many shares of Amgen are outstanding?
Amgen has 156B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.